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Starting and stopping preventive chemotherapy (PC) for soil-transmitted helminthiasis is typically based on the prevalence of in-
fection as measured by Kato-Katz (KK) fecal smears. Kato-Katz-based egg counts can vary highly over repeated stool samples and 
smears. Consequentially, the sensitivity of KK-based surveys depends on the number of stool samples per person and the number 
of smears per sample. Given finite resources, collecting multiple samples and/or smears means screening fewer individuals, thereby 
lowering the statistical precision of prevalence estimates. Using population-level data from various epidemiological settings, we as-
sessed the performance of different sampling schemes executed within the confines of the same budget. We recommend the use of 
single-slide KK for determining prevalence of moderate-to-heavy intensity infection and policy decisions for starting and continuing 
PC; more sensitive sampling schemes may be required for policy decisions involving stopping PC. Our findings highlight that guide-
lines should include specific guidance on sampling schemes.
Keywords.  fecal egg counts; Kato-Katz; moderate-to-heavy infection; prevalence; soil-transmitted helminths.
Soil-transmitted helminthiases (STHs), caused by Ascaris 
lumbricoides, Trichuris trichiura, and hookworms, affect ap-
proximately 1.5 billion people worldwide. The World Health 
Organization (WHO) has targeted STH for control as a public 
health problem by 2020 through regular preventive chemo-
therapy (PC), with control defined as prevalence of moderate-
to-heavy (MH) intensity infection ≤1% [1–3]. The WHO 
further recommends that decisions on starting, continuing, and 
stopping PC are based on estimates of STH prevalence (any in-
tensity) in school-age children as measured by the classic para-
sitological Kato-Katz (KK) fecal smear [1–3].
Kato-Katz-based egg counts vary highly within individuals 
over repeated stools samples from different days and between 
repeated slides based on the same stool sample. Consequently, 
surveys based on multiple stool samples per individual and/or 
multiple slides per stool sample typically yield higher prevalence 
estimates than when examining 1 slide per person [4]. However, 
increasing the number of slides per sample or the number of stool 
samples per person (requiring visiting a study site multiple days) 
means fewer individuals can be tested for the same amount of re-
sources, thereby lowering the statistical precision of prevalence es-
timates. The trade-off between sensitivity and precision of survey 
results will be different for prevalence of any versus MH intensity 
infection, because examining multiple slides increases sensitivity 
but does not affect estimates of mean intensity of infection [4]. 
The WHO currently provides a blanket recommendation that 
prevalence of STH should be evaluated based on a single stool 
sample per child [2], without any specific recommendation for the 
number of slides that should be prepared per sample.
In this study, we explore how different sampling schemes 
used within the confines of the same budget affect the sensi-
tivity of surveys to detect infection (any and MH intensity) and 
the statistical precision of surveys results. We do so by bootstrap 
analysis of existing datasets from different epidemiological set-
tings where multiple stool samples were collected and/or stool 
samples were examined multiple times.
METHODS
Datasets
Four datasets covering 6 countries were analyzed; Appendix A 
provides an overview of characteristics of each dataset, including 
geographical location, sample size, dominant STH species, and 
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history of control. The first dataset constituted information from 
a population-based survey conducted in 2008 in a subcounty of 
eastern Uganda [5]. Members of all households in the subcounty 
were asked to provide 2 stool samples on 2 consecutive days 
(26.3% of participants provided only 1 sample); each sample was 
examined with duplicate KK. The second dataset held baseline 
data from an epidemiological study in 45 villages in southern 
India [6], including up to 3 stool samples per individual (10.8% 
and 6.4% of individuals returned only 1 or 2 stools samples, re-
spectively), each sample examined once with the McMaster egg 
counting technique (which yields qualitatively similar results to 
KK [7]) if initial screening with saline and iodine wet preparation 
was positive. The third dataset constituted baseline data from 
the TUMIKIA study, a cluster-randomized trial in 120 clusters 
of villages in Kenya [8, 9], in which 1 individual per household 
was tested with duplicate KK based on a single stool sample. The 
fourth dataset contained baseline data from the Starworms study 
[10–12] in which school-age children in Ethiopia, Lao People’s 
Democratic Republic, and Tanzania were tested using (among 
other techniques) duplicate KK performed on a single stool 
sample. The Starworms study was the only study in which stool 
samples were homogenized before preparing the fecal smears. 
Hookworm was the dominant STH species in all sites, except for 
the Starworms study sites, where roundworm (A lumbricoides) 
and whipworm (T trichiura) were equally prevalent.
Datasets were prepared in such a way that all individuals 
within a single dataset had the same number of records by ex-
plicitly including incomplete or missing records as missing 
values, to account for the reality that stool sample collection, 
slide preparation, and/or slide examination may be incomplete 
or fail.
Data Analysis
For each dataset, we defined a set of sampling schemes ac-
cording to which the survey might have been (alternatively) 
conducted within the confines of the available data. We de-
fined sampling schemes as a× b, where a is the number of 
stool samples per person, and b is the number of repeated slides 
per sample. Expected differences in prevalences (absolute and 
relative, a× b = 1× 1 as reference) resulting from different 
sampling schemes were quantified based on 10  000 repeated 
bootstraps [13]. Within each bootstrap iteration, we started by 
sampling a number of individuals (with replacement) equal to 
the original size of the dataset. Then, for each individual, we 
randomly shuffled stools samples (if more than 1 was available, 
keeping together repeated slides based on the same sample), 
and for each stool sample, we randomly shuffled repeated 
slides (if any). For each sampling schemea× b, we saved the 
bootstrapped egg counts from the a first stool samples and b 
first slides per sample for each individual in the bootstrapped 
data. This way, within each bootstrap iteration, the first exam-
ined slide of each individual included in a multislide sampling 
scheme was also included in the 1×1 reference scheme, allowing 
us to directly compare results of the different sampling schemes 
as if executed on the same set of candidate people.
Results of each sampling scheme were summarized in terms 
of prevalence of any infection and prevalence of MH intensity 
infection. Individuals were considered positive if at least 1 of 
their slides was positive for eggs. Individuals were considered 
positive for MH intensity infection based on the number of 
eggs per gram feces (epg) averaged over all slides, using cutoffs 
for MH intensity infection as defined by WHO [2]: ≥2000 epg 
for hookworm species, ≥1000 epg for T trichiura, and ≥5000 
epg for A lumbricoides. Individuals with all egg counts missing 
were discarded from the bootstrapped data before calculations, 
without replacement.
To compare sensitivity and statistical precision of different sam-
pling schemes when executed within the confines of the same budget, 
we performed a second bootstrap procedure. First, we defined a 
budget B (range, 50 up to 2000), where the value of Bis the number of 
individuals that can be tested within a 1×1 sampling scheme. Then, for 
the other schemes, we calculated the number of people that could be 
tested with the same budget as follows: Na×b = B/ (Sa×b × Cb × a)
. Here, Sa×b is the total number of slides per person in scheme a× b 
(eg, 4 for a 2×2 scheme), and Cb is the relative cost per slide for single 
(C1 = 1) or duplicate slides (C2 = cost per slide1×2cost per slide1×1 =
2.41/2
1.94 = 0.621, 
based on published cost estimates [14]). The last term a in the de-
nominator is included as a multiplier assuming that collecting a sam-
ples per person will increase cost per slide a-fold due to having to visit 
the study site a days. For instance, given a budget worth the cost of 
testing 500 individuals in a 1×1 scheme (B = 500), the number of in-
dividuals that can be tested in a 1×2 scheme (Sa×b = 2, Cb = 0.621, 
a = 1) would be N1×2 = 500/ (2× 0.621× 1) = 402, rounded 
down to the nearest integer. Likewise, for a 2×1 scheme (Sa×b = 2, 
Cb = 1, a = 2), the number of individuals that can be tested would 
be N2×1 = 500/ (2× 1× 2) = 125, and for a 2×2 scheme 
(Sa×b = 4, Cb = 0.621, a = 2) the number of individuals would be 
N2×2 = 500/ (4× 0.621× 2) = 100.
For each value of budget B, we performed 10 000 repeated 
bootstrap iterations. Each bootstrap iteration started by sam-
pling B individuals (with replacement) for the 1×1 scheme and 
shuffling stools samples and repeated slides (if any) as before. 
Subsequently, for each non-1×1 sampling scheme, we selected 
the Na×b first people from the bootstrapped dataset, and we 
selected the first a stool samples per individual and first b 
slides per sample. This way, again, all individuals included in 
the non-1×1 schemes (and their first examined slide) were also 
included in the 1×1 reference scheme. Prevalences were calcu-
lated and compared as in the first bootstrap analysis. Results 
of the budget-constrained bootstrap analysis were summarized 
by means of boxplots (illustrating the variation in prevalence 
of any and/or MH infections), and the proportion of bootstrap 
iterations in which the estimated prevalence from a non-1×1 
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scheme was higher than the corresponding estimate from the 
1×1 reference scheme.
RESULTS
Table 1 provides the added value of performing a second slide 
from the same stool sample. In the Ugandan and Kenyan 
datasets, this significantly increased the estimated preva-
lence by a factor of 1.25 for low-endemic settings (prevalence 
≤5%) and 1.10 in highly endemic settings (prevalence ≥45%), 
whereas absolute difference in prevalence were highest for 
more highly endemic settings (see Table 1 for details). For 
the Starworms data, testing a second slide did not increase 
estimated prevalences, which was due to the reduced varia-
tion between repeated slides resulting from stool homogeni-
zation [15]. This is also reflected by the relatively low number 
of discordant (zero/nonzero) pairs of duplicate egg counts 
(eg, 0.8% of pairs in Tanzania hookworm data vs 9.0% in the 
Ugandan data). This pattern was similar for all 3 STH spe-
cies and in all 3 countries covered by the Starworms study. 
Appendix B summarizes the added value of collecting addi-
tional stool samples per person, which increased prevalences 
by up to a factor of 1.59 (2×1 scheme) and 1.98 (3×1 scheme). 
Again, absolute increases in prevalence were highest in more 
highly endemic settings (see Appendix B for details). In the 
Indian data, the 3×1 scheme increased prevalence to a lesser 
extent (1.25 relative to 2×1 scheme) compared with the 2×1 
scheme (1.59 relative to 1×1 scheme). In the Ugandan dataset, 
the increase in prevalence was higher in the 2×1 scheme 
(1.45) than in the 1×2 scheme (1.19).
Prevalence of MH intensity infection did not differ signif-
icantly between any of the sampling schemes for any of the 
datasets, because the 95% confidence intervals for relative 
differences always included the value 1.0. Only in the Indian 
data did estimates tend to decline with additional stool sam-
ples (again nonsignificantly), which could be explained by 
the 2-tiered testing method in which eggs were only counted 
if initial screening of the sample was positive. The resulting 
introduction of zero counts (where eggs might have actu-
ally been found with the McMaster) caused mean egg counts 
for individuals to decline when more stool samples were in-
cluded in the prevalence calculation.
Figure 1 shows that when sampling schemes are restrained 
by the same budget, the reference 1×1 scheme produced survey 
prevalence estimates with the highest statistical precision, be-
cause it included the highest number of people. In general, 
non-1×1 schemes produced higher prevalence estimates, but 
with a risk of occasionally finding a lower prevalence than the 
1×1 scheme. However, in the Starworms study sites, non-1×1 
schemes only increased statistical uncertainty of prevalence es-
timates without a gain in sensitivity (Figure 1D; see Appendix 
C for all countries and worm species in the Starworms data). 
For all datasets but the Starworms data, the risk of accidentally 
finding a lower prevalence with a non-1×1 scheme decreased 
with higher budgets. The minimum budget to reduce this risk 
to ≤5% depended on endemicity (eg, a budget equivalent to the 
cost of testing 1030 and 122 individuals in a 1×1 scheme for 
the lowest and highest endemicity strata in the Kenyan data, 
Appendix D). In the endemicity-stratified analysis of the Kenyan 
data, the choice of scheme (1×1 vs 1×2) determined the proba-
bility that the estimated prevalence of any infection was under 
or above a policy-relevant threshold value (Appendix E). Figure 
2 illustrates the impact of sampling scheme on prevalence of 
MH intensity infection: non-1×1 schemes only increased sta-
tistical uncertainty without a gain in sensitivity. Results were 
qualitatively similar for all species and sites in the Starworms 
data (Appendix F).
Table 1. Differences in Estimates of Prevalence of Hookworm Infection (Any Intensity) Based On Single (1×1) or Duplicate Slide (1×2) Examination of a 
Single Stool Samplea 
Dataset 
Expected Results for 1×1 Scheme
Expected Difference in Prevalence Between 
1×2 and 1×1 Schemes
Prevalence of Infection (95% CI) Mean Egg per Gram (95% CI) Absolute (95% CI) Relative (95% CI)
Mulanda, Tororo, Uganda 23.4 (21.3–25.4) 258 (181–350) 4.5 (3.3–5.5) 1.19 (1.15–1.24)
Kwale, Kenya (TUMIKIA) 16.7 (16.1–17.2) 168 (149–191) 2.4 (2.2–2.6) 1.14 (1.13–1.16)
 Prevalence ≤5% 2.4 (1.8–2.9) 11 (5–17) 0.6 (0.3–0.9) 1.25 (1.13–1.40)
 Prevalence 5%–15% 8.8 (8.1–9.5) 81 (62–105) 1.5 (1.2–1.8) 1.17 (1.14–1.21)
 Prevalence 15%–25% 17.2 (16.1–18.3) 167 (135–200) 2.6 (2.1–3.1) 1.15 (1.12–1.18)
 Prevalence 25%–35% 26.1 (24.6–27.7) 299 (220–417) 3.9 (3.2–4.7) 1.15 (1.12–1.18)
 Prevalence 35%–45% 35.5 (33.1–37.8) 381 (295–480) 4.4 (3.3–5.5) 1.12 (1.09–1.16)
 Prevalence >45% 48.1 (45.2–51.2) 465 (381–556) 5.0 (3.6–6.4) 1.10 (1.07–1.14)
Abbreviations: CI, confidence interval.
aEstimates are based on 10 000 bootstraps of the entire datasets. For the Kenyan data, data were also stratified based on overall prevalence at the cluster level (N = 120). Results for the 
Starworms data are not shown because differences between the 2 sampling schemes were nonsignificant for all of the worm species in all of the countries. Absolute differences are ex-
pressed as percentage points; relative differences are expressed as ratios of 1×2 over 1×1. The 95% CI is based on the 2.5th and 97.5th percentiles of bootstrap results.
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DISCUSSION
We show that when designing surveys for assessing the epide-
miological situation of STH within a finite budget, a trade-off 
exists between the sensitivity of the survey to detect infection 
and the statistical precision of survey results. Importantly, gains 
in sensitivity only apply to prevalence of infection (any inten-
sity) based on unhomogenized stools and are most pronounced 
in low-endemic settings (on a relative scale). For prevalence of 
MH intensity infection, sampling multiple stool samples per 
person and/or slides per sample only increases statistical uncer-
tainty and not sensitivity.
Because prevalence estimates depend on the choice of sam-
pling scheme, it is important that threshold values for policy 
decision regarding starting, changing, or stopping PC are de-
fined in conjunction with a clearly specified survey strategy, ie, 
with explicit mention of the numbers of samples per person and 
slides per sample tested. If deviating survey strategies are used, 
survey results should be translated to the standard scale, using 
the relative differences (and associated uncertainty) estimated 
here and elsewhere [4]. Based on our analyses, we recommend 
that policy decisions for starting and continuing PC are based 
on a 1×1 sampling scheme, because survey results will then 
be most stable, ensuring the most consistent policy. However, 
when deciding whether to stop PC (threshold prevalence of any 
infection of 2% [2]), sensitivity of the sampling scheme will be 
particularly important because false-negative findings may lead 
to stopping PC prematurely. In such situations the higher costs 
of multiple sampling probably outweigh the costs of potentially 
having to restart the control program. Schemes based on mul-
tiple stool samples per person will be of particular value if a 
survey using the 1×1 scheme (executed within the confines of 
the same budget) would require spending multiple days in a site 
(eg, for large populations), because this would partially negate 
the additional costs of having to spend multiple days to collect 
multiple stool samples per person. We further expect that for 
low-endemic settings, relative gains in sensitivity when using 
multiple stool samples per person will be higher than estimated 
here, because prevalence will typically be lower than in the data 
used here (lowest prevalence of infection approximately 9% in 
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Figure 1. Sensitivity and precision of different sampling schemes for detection of hookworm infection, when based on the same overall budget. Budget is expressed as 
the number of individuals that can be tested in the context of a 1×1 scheme (1 stool sample collected per person and 1 slide tested per sample). Numbers between brackets 
under the sampling scheme indicators (“1×1”, “1×2”, etc) represent the number of people who were tested in that scheme, given the budget. Boxes represent the median 
and interquartile range (25th and 75th percentiles) of the bootstrapped prevalences; whiskers cover the range of bootstrapped values up to a distance of 1.5 times the inter-
quartile range from the outer hinges of the box. Estimated are based on 10 000 bootstraps. (A) Ugandan dataset [5]; (B) Indian dataset [6]; (C) Kenyan data (TUMIKIA) [8, 9]; 
(D) Tanzanian dataset (Starworms) [10–12].
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Indian data), and because relative gains in sensitivity increase 
with declining prevalence (Kenyan data).
A major strength of our analysis and improvement over 
previous analyses [4] is that we include cost considerations 
when comparing sampling schemes, while at the same time 
accounting for the reality that not all individuals return (all) 
samples and that slides preparation and examination may fail. 
Context-dependent costs of sampling schemes [16] can be 
easily accounted for by multiplying the budget value in our 
analysis with the cost per slide in a 1×1 scheme in that partic-
ular context. Furthermore, context-dependent cost differences 
between sampling schemes can be easily included by adapting 
2 parameters for cost per sample and cost per slide. However, 
to predict the outcomes of sampling schemes for epidemio-
logical situations far outside the data, such as situations with 
very low infection levels after a prolonged period of PC, will 
require either of 2 approaches. The first is the collection of data 
from those contexts and analyzing them in the same fashion as 
done here. The ongoing Deworm3 study [17] is expected to gen-
erate such data (including a 1×2 KK scheme), in the context of 
intense school-based and community-based PC for STH after 
an initial period of community-wide PC for lymphatic filariasis. 
The second approach is to use transmission models to predict 
the distribution of infection intensities over time during PC 
and combine these with a statistical model for the distribution 
of egg counts in stool samples and slides [15]. This is the sub-
ject of ongoing work for both STH and schistosomiasis within 
the NTD Modelling Consortium, which focuses on the devel-
opment of transmission models that realistically account for 
heterogeneity in exposure to transmission and uptake of PC in 
populations to make policy-relevant predictions of the impact 
of control efforts [18–24].
Homogenization results in a more Poisson-like distribu-
tion of repeated egg counts [15], which has lower variation in 
contrast to the typically overdispersed, negative binomial dis-
tribution of repeated egg counts [25, 26]. This means that for 
individuals with low or high egg loads (which typically consti-
tute the majority of endemic populations due to overdispersed 
worm loads), test sensitivity will be maximized with 1 slide per 
sample, which matches our finding of no increase in sensitivity 
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Figure 2. Sensitivity and uncertainty of different sampling schemes for detection of moderate-to-heavy intensity hookworm infection in the general population, based on 
the same overall budget. Budget is expressed as the number of individuals that can be tested in the context of a 1×1 scheme (1 stool sample collected per person and 1 slide 
tested per sample). Numbers between brackets under the sampling scheme indicators (“1×1”, “1×2”, etc) represent the number of people who were tested in that scheme, 
given the budget. Boxes represent the median and interquartile range (25th and 75th percentiles) of the bootstrapped prevalences; whiskers cover the range of bootstrapped 
values up to a distance of 1.5 times the interquartile range from the outer hinges of the box. Estimated are based on 10 000 bootstraps. (A) Ugandan dataset [5]; (B) Indian 
dataset [6]; (C) Kenyan data (TUMIKIA) [8, 9]; (D) Tanzanian dataset (Starworms) [10–12].
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for multiple-slide KK based on homogenized stools. Repeated 
slides based on homogenized stools are therefore unlikely to 
noticeably increase survey sensitivity, but sampling stool sam-
ples over multiple days will still increase survey sensitivity. 
Theoretically, stool homogenization increases the sensitivity of 
surveys to detect infection, with the highest absolute increase in 
individuals with moderate to high egg densities [27]. Whether 
the sensitivity of a single slide based on homogenized stool is 
higher than that of multiple slides based on unhomogenized 
stool depends on the overall egg density in a stool sample and 
therefore the distribution of egg densities in the population. 
These complexities warrant a more detailed evaluation of the 
performance of different sampling strategies in context of con-
trol programs, which again requires a combination of transmis-
sion models and statistical models.
As for the appropriateness of the WHO-recommended 
thresholds for STH policy, these cannot be evaluated by this 
study, because their appropriateness depends on the following: 
(1) whether they adequately reflect to what extent STHs pose 
a significant public health problem, and (2) whether starting, 
changing, or stopping PC around the current threshold values 
actually results in achieving the target of <1% prevalence MH 
intensity infection. The first aspect needs to be addressed by 
quantifying the association between infection levels and mor-
bidity and their dynamics during control. The second aspect has 
been partly addressed by a recent modeling study, which sug-
gested that current thresholds for scaling down PC frequency 
are inappropriate because infection levels will likely bounce 
back to levels above the current morbidity target [28]. A  fol-
low-up modeling study further demonstrated how the positive 
predictive value of the prevalence of infection (any intensity) in 
a sample of sentinel villages for having reached the morbidity 
target in a wider geographical area highly depends on precontrol 
endemicity, the dominant STH species, number of sentinel vil-
lages sampled, and variation in infection levels within the wider 
geographical area [29].
CONCLUSIONS
In conclusion, we show that different sampling strategies lead 
to considerable variation in the policies recommended under 
current WHO guidelines, highlighting the need to link thresh-
olds for decision making to specific sampling schemes. When 
policy decisions are based on KK, we recommend the use of 
single slides, unless the decision involves stopping PC, in which 
case multisample KK is better, in particular in sites where a 
single-slide survey of the population requires multiple days. 
Prevalence of MH intensity infection should always be evalu-
ated using a single slide per person.
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